Figure 1: Identification of a novel ligand consensus sequence for the N1-Src SH3 domain. | Scientific Reports

Figure 1: Identification of a novel ligand consensus sequence for the N1-Src SH3 domain.

From: Inhibition of N1-Src kinase by a specific SH3 peptide ligand reveals a role for N1-Src in neurite elongation by L1-CAM

Figure 1

(a) Schematic of the kinase assay used to validate the effect of potential SH3 domain ligands on the phosphorylation of an ideal tyrosine motif (Y in bold) located upstream of a 10 aa linker and 12 aa phage peptide. (b) GST-Y-PDN1–6 substrates at 0.3, 0.9, 2.8 or 8.3 μM were phosphorylated in vitro with 5 nM C- or N1-Src at 30 °C and the phosphorylation detected by anti-phosphotyrosine immunoblot. Immunoblots are representative of three independent experiments. (c) Alignment of the phage display peptides ranked by N1-Src selectivity derived from results in (b). Shaded residues represent the common consensus sequence. (d) Kinetic measurements for GST-Y (Y), GST-Y-PDN1 or GST-Y-PDN2 substrates (see a for structure) in the presence of 5 nM C- or N1-Src. Data were plotted as mean Km (μM) ± SEM (n = 3). *P < 0.05 by ANOVA and post-hoc Tukey test. (e) GST-Y-PDN1 substrates with the indicated point mutations (see insert) at 8.3 μM were phosphorylated by 5 nM N1-Src and the extent of phosphorylation was measured by densitometry of phosphotyrosine immunoreactivity. Data were plotted as arbitrary units (±SEM, n = 3), normalised to the wild-type (WT) PDN1 peptide. **P < 0.01; ***P < 0.001 by ANOVA and post-hoc Tukey test.

Back to article page